This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Pregabalin and gabapentin set to become controlled drugs


Useful for a small group of people, but addictive and abusable. In the acute setting and some cases of true neuropathic pain, have some benefits. Like opioids, the problem is they induce euphoria - and persistent pain is a complex phenomenon with low mood being one of the components. So we prescribe a drug which isnt helping the pain, but it temporarily makes patients feel better for a few hours - so of course they will like it. But is it much better than asking them to drinking a few pints to take their minds off things? No - very short term, great - but long term, harm and dependence have potential to rear their heads. Persistent pain doesnt respond well to pharmacology - it needs a psychosocial approach (Pain toolkit is good as a starting point) - this takes time, we dont have much of it, nor resources. So can see why prescribing a short acting euphoriant can be seen initially as success.....until they come back for more wanting higher doses........Same principle as applies to opioid prescribing concerns - and benzos etc....

Posted date

24 Sep 2017

Posted time